Skip to content

Cardiac Amyloidosis

When to Suspect Amyloidosis

  • Increased LV wall thickness without a sufficient loading condition
  • HFpEF with restrictive physiology
  • Apical-sparing strain pattern
  • Biatrial enlargement or thickened interatrial septum
  • Conduction disease or atrial fibrillation
  • Low voltage relative to LV thickness
  • Carpal tunnel syndrome, lumbar stenosis, biceps rupture, neuropathy, or orthostasis

Warning

Normal ECG voltage does not exclude cardiac amyloidosis.

Diagnostic Algorithm

  1. Obtain serum free light chains plus serum and urine immunofixation.
  2. If any monoclonal study is abnormal → evaluate urgently for AL amyloidosis; PYP cannot independently establish ATTR.
  3. If monoclonal studies are negative → perform Tc-99m PYP scintigraphy with SPECT.
  4. Grade 2–3 myocardial uptake with a compatible phenotype establishes ATTR-CM noninvasively.
  5. After ATTR is diagnosed → perform TTR genetic testing.

The critical trap

Bone-avid tracer uptake is not specific for ATTR when a monoclonal protein is present. AL must be excluded before calling the scan diagnostic of ATTR.

Tc-99m PYP Interpretation

Grade Myocardial uptake
0 None
1 Less than rib uptake
2 Equal to rib uptake
3 Greater than rib uptake with reduced bone activity
  • Grade 0: ATTR-CM unlikely
  • Grade 1: equivocal; consider CMR or biopsy
  • Grade 2–3: diagnostic of ATTR-CM only when AL is excluded and SPECT confirms myocardial uptake

SPECT or SPECT/CT is required to distinguish myocardial uptake from residual blood pool or overlying bone.

Heart-to-Contralateral Ratio

The H/CL ratio supports interpretation but should not be used alone:

  • ≥1.5 at 1 hour is abnormal in an appropriate protocol
  • ≥1.3 at 3 hours is abnormal in an appropriate protocol

Visual grading and SPECT localization take priority.

False Positives

  • Residual blood pool
  • Recent myocardial infarction
  • Rib fracture or overlying bone activity
  • Hydroxychloroquine toxicity
  • AL amyloidosis
  • Incorrect ROI placement

False Negatives

  • Early ATTR disease
  • Some hereditary TTR variants
  • Inadequate acquisition or processing
  • Minimal myocardial amyloid burden

Board Pearls

  • Rule out AL before interpreting PYP as ATTR.
  • SPEP alone is insufficient; use serum and urine immunofixation plus free light chains.
  • Grade 2 planar uptake without SPECT confirmation may represent blood pool.
  • CMR supports cardiac amyloidosis but does not reliably determine amyloid type.
  • Genetic testing follows confirmation of ATTR and distinguishes variant from wild-type disease.

References